Development and assessment of a modified pediatric crohn disease activity index

Journal of Pediatric Gastroenterology and Nutrition

Volumn 51, Issue 2, 2010, Pages 232-236

  Leach, Steven T ^a   Nahidi, Lily ^a   Tilakaratne, Samantha ^b   Day, Andrew S ^a   Lemberg, Daniel A ^b  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b SYDNEY CHILDREN'S HOSPITAL   (Australia)

Author keywords

Crohn disease; fecal calprotectin; modified PCDAI

Indexed keywords

C REACTIVE PROTEIN; CALGRANULIN;

ADOLESCENT; ADULT; ARTICLE; CALCULATION; CHILD; CLINICAL ASSESSMENT; CLINICAL EVALUATION; CROHN DISEASE; DISEASE ACTIVITY; DISEASE COURSE; FEMALE; HUMAN; LABORATORY; MAJOR CLINICAL STUDY; MALE; PHYSICIAN; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD;

ADOLESCENT; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CHILD; CROHN DISEASE; FECES; HUMANS; LEUKOCYTE L1 ANTIGEN COMPLEX; PEDIATRICS; SEVERITY OF ILLNESS INDEX;

EID: 77955232028     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/MPG.0b013e3181d13609     Document Type: Article

References (12)

1. Hyams JS, Ferry GD, Mandel FS, et al. Development and validation of a pediatric Crohn's disease activity index. J Pediatr Gastroenterol Nutr 1991;12:439-447
2. Otley A, LoonenH, Parekh N, et al. Assessing activity of pediatric Crohn's disease: which index to use? Gastroenterology 1999;116:527-531
3. Sidler MA, Leach ST, Day AS. Fecal S100A12 and fecal calprotectin as noninvasive markers for inflammatory bowel disease in children. Inflamm Bowel Dis 2008;14:359-366
4. Bartholomeusz FD, Shearman DJ. Measurement of activity in Crohn's disease. J Gastroenterol Hepatol 1989;4:81-94.
5. Hyams JS, Mandel F, Ferry GD, et al. Relationship of common laboratory parameters to the activity of Crohn's disease in children. J Pediatr Gastroenterol Nutr 1992;14:216-222
6. Loonen HJ, Griffiths AM, Merkus MP, et al. A critical assessment of items on the Pediatric Crohn's Disease Activity Index. J Pediatr Gastroenterol Nutr 2003;36:90-95
7. Mack DR, Langton C, Markowitz J, et al. Laboratory values for children with newly diagnosed inflammatory bowel disease. Pediatrics 2007; 119:1113-1119
8. Barnes BH, Borowitz SM, Saulsbury FT, et al. Discordant erythrocyte sedimentation rate and C-reactive protein in children with inflammatory bowel disease taking azathioprine or 6-mercaptopurine. J Pediatr Gastroenterol Nutr 2004;38:509-512
9. Tilakaratne S, Lemberg DA, Leach ST, et al. C-reactive protein and disease acitivity in children with Crohn's disease. Dig Dis Sci 2010; 55:131-136
10. Chung-Faye G, Hayee Bh, Maestranzi S, et al. Fecal M2-pyruvate kinase (M2-PK): a novel marker of intestinal inflammation. Inflamm Bowel Dis 2007;13:1374-1378
11. Costa F, Mumolo MG, Bellini M, et al. Role of faecal calprotectin as non-invasive marker of intestinal inflammation. Dig Liver Dis 2003; 35:642-647
12. Kane SV, Sandborn WJ, Rufo PA, et al. Fecal lactoferrin is a sensitive and specific marker in identifying intestinal inflammation. Am J Gastroenterol 2003;98:1309-1314